Definitive Contract 75F40122C00102

Award Date 8/8/22
Potential Completion Date 2/7/28
Potential Value $484K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Little Rock, AR 72205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a Firm Fixed Price contract to the Arkansas Department of Health (ADH) for Certified Mammography Facility Inspections under the Mammography Quality Standards Act (MQSA) program. The contract has a ceiling value of $27,695.20 and a performance period through April 30, 2005. This is a definitive contract with no set-aside designation. Additionally, ADH holds two significant federal contract Indefinite Delivery Vehicles (IDVs) - a $3.2 million CDC...
This contract was awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS), a state government entity, to conduct inspections of certified non-federal mammography facilities in Arizona. The contract, valued at $1,911,936.08, is a definitive, firm-fixed-price contract with a period of performance through March 29, 2028. The original solicitation was a sole-source procurement, as the inspections require legal authority under state law and experience...
The Department of Health and Alabama (ADPH) was awarded a $1,573,686.15 definitive contract by the Food and Drug Administration (FDA) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This sole-source contract, which runs through March 31, 2028, is part of a larger $5,751,201.41 Indefinite Delivery Contract (IDC) the FDA has with ADPH for various inspection and compliance...
<p>The U.S. Food and Drug Administration (FDA) awarded a $359,633.67 firm fixed price definitive contract to the Alaska Division of Public Health for ALASKA MQSA STATE INSPECTIONS. The contract has an ultimate completion date of March 4, 2028. There is no set-aside designation for this award. The contract requires the Alaska Division of Public Health to provide MQSA state inspections services in Anchorage, Alaska.</p>
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
The federal contract award HHSF223201510122C was issued by the Food and Drug Administration (FDA), a civilian agency, to the Arkansas Department of Health (ADH) in Little Rock, Arkansas. This is a definitive, firm-fixed price contract with a ceiling value of $408,478.22 and a completion date of September 29, 2018. The contract is for an &quot;Arkansas Food Contract&quot; and was not set aside. ADH, as a state government entity, has received various federal contracts and grants from agencies like...
The Food and Drug Administration (FDA) awarded a $364,857.29 firm-fixed-price contract to the State of Utah Department of Environmental Quality (Environmental Quality Ut Dept), a U.S. state government entity, to conduct inspections of certified non-federal mammography facilities within the state. This contract, which runs through January 2028, is part of the Mammography Quality Standards Act (MQSA) program and is a sole-source award with no set-aside designation. Environmental Quality Ut Dept,...
The Missouri Department of Health and Senior Services (MDHSS) has been awarded a $1,558,251 firm-fixed-price contract by the Food and Drug Administration (FDA) to conduct inspections of certified non-federal mammography facilities in Missouri. This contract, which runs through September 2027, supports the Mammography Quality Standards Act (MQSA) by ensuring compliance with quality standards. As the state health agency, MDHSS possesses the legal authority and regulatory experience required to...
The Food and Drug Administration (FDA) awarded a $236,714.59, firm fixed price definitive contract to the New Hampshire Department of Health and Human Services (NH DHHS) to perform inspections of certified non-federal mammography facilities in New Hampshire. This contract, which runs through March 31, 2028, is to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was not set aside and was competitively awarded to the state agency, which...
This firm-fixed-price contract was awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health &amp; Environment (CDPHE), a state government entity, to provide Mammography Quality Standards Act (MQSA) inspections. The contract has a ceiling value of $453,010.00 and a period of performance from March 1, 2003, to February 28, 2006. CDPHE, a subsidiary of the City of Lakewood, has a long history of executing federal contracts and grants across various public health...

The Food and Drug Administration (FDA) awarded a $483,881.81 firm-fixed-price definitive contract to the Arkansas Department of Health (ADH) for the "ARKANSAS MQSA INSPECTION CONTRACT". This contract supports inspections of certified non-federal mammography facilities in Arkansas to ensure compliance with the Mammography Quality Standards Act (MQSA). ADH was selected as the sole source provider for this requirement due to its legal authority under state law to access commercial establishments for regulatory inspections and its experience with MQSA procedures and corrective actions. The contract has an ultimate completion date of February 7, 2028. This award is not associated with a set-aside. The contract is part of a larger FDA initiative to engage state and local organizations to conduct MQSA inspections across the country.

Generated 2/1/25, 10:48 AM